Oral edaravone ameliorates behavioral deficits and pathologies in a valproic acid-induced rat model of autism spectrum disorder.
Saved in:
| Title: | Oral edaravone ameliorates behavioral deficits and pathologies in a valproic acid-induced rat model of autism spectrum disorder. |
|---|---|
| Authors: | Lu, Xiao-Yu1 (AUTHOR), Li, Meng-Qing1 (AUTHOR), Li, Yong-Tao2 (AUTHOR), Yao, Jia-Yu1 (AUTHOR), Zhang, Lin-Xuan1 (AUTHOR), Zeng, Ze-Hao1 (AUTHOR), Yu-Liu1 (AUTHOR), Chen, Zhao-Rong1 (AUTHOR), Li, Chang-Qi1 (AUTHOR), Zhou, Xin-Fu1,2,3 (AUTHOR) xfzhou@szauzone.com, Li, Fang1 (AUTHOR) fangli@csu.edu.cn |
| Source: | Neuropharmacology. Nov2024, Vol. 258, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00283908 |
|---|---|
| DOI: | 10.1016/j.neuropharm.2024.110089 |
